Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CREBBP inhibitors(cAMP-response element binding protein inhibitors), EP300 inhibitors(Histone acetyltransferase p300 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H31N3O2 |
InChIKeyVBTDHMQUNCGCSZ-SBLNNXNXSA-N |
CAS Registry2422136-44-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | US | 13 Jul 2021 |